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Abstract
In July 2011, the United States Food and Drug Administration issued draft guidance concerning the regulation of
mobile medical applications (applications on a wireless device that are used as accessories to medical devices or to
convert a mobile platform to a medical device). While the suggestion of regulation is rooted in patient safety,
concerns about limits on innovation and discovery as well as the evolving nature of both mobile health and
current healthcare delivery have emerged. This article discusses the prevalence of mobile health, the context of
regulation concerning mobile medical applications, and implications for the future.
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Introduction
Mobile health, or more commonly, mHealth, is ‘the use
of wireless communication devices to support public
health and clinical practice’ [1]. Mobile devices are hand-
held in nature and include mobile phones, personal digi-
tal assistants, patient monitoring devices, and other
wireless devices. mHealth applications are receiving
increased attention largely due to the global penetration
of mobile technologies. It is estimated that over 85% of
the world’sp o p u l a t i o ni sn o wc o v e r e db yac o m m e r c i a l
wireless signal, with over 5 billion mobile phone sub-
scriptions [2]. The availability of mobile technology has
advanced infrastructure development in low- and mid-
dle-income countries beyond roads and electricity [2].
Mobile medical applications range from communication
between individuals and health systems (such as call cen-
ters, appointment reminders, treatment compliance) to
health monitoring and surveillance (including surveys,
patient monitoring devices), and access to information at
the point of care (health records, decision support).
The Royal Tropical Institute [3] defined eight mHealth
application areas. Education and awareness systems are
those that provide information about health promotion
and disease prevention. Point-of-care support and diag-
nostics are used to provide the clinician with reference
information for clinical care as well as decision support
for diagnostics. Patient monitoring provides patients with
support for treatment adherence. Disease and epidemic
outbreak surveillance provides real-time tracking of
infectious diseases. Emergency medical response systems
provide alerts for accidents and disasters. Health infor-
mation systems manage data used in clinical care.
mLearning provides mobile platforms for educational
support for health professionals. Finally, health financing
applications are those that facilitate the use of smart
cards or vouchers for mobile payments. The purpose of
this article is to explain the context for regulation, iden-
tify implications of regulation, and discuss future per-
spectives of mHealth applications.
Of the myriad of mobile medical applications available
to clinicians and their patients, a small subset has been
recommended for regulatory oversight in the United
States. These are mobile applications whose intended use
is similar to that of an existing medical device. Vos and
Parker [4] state ‘Medical devices by their very nature
have the potential to present a hazard - to be a source of
harm in normal use, and more so if misused. Regulations
are therefore a necessary instrument to safeguard users
from undue and unnecessary risks and are based on the
principle of mitigating, to an acceptable level, the poten-
tial of a device to cause harm.’ They further explain that
the purpose of regulation is not only geared toward man-
ufacturers, but also to provide guidelines to support pro-
duct development in a manner which results in an
appropriate risk-benefit ratio.
Since publication of ‘Crossing the Quality Chasm’,a
report by the Institute of Medicine (IOM) that focused on
creating health system solutions to mitigate medical error,
health information technology (Health IT) has been her-
alded as a vehicle to enhance patient safety and provide
Correspondence: amy.barton@ucdenver.edu
University of Colorado, Anschutz Medical Campus, College of Nursing, 13120
East 19
th Avenue, Aurora, Colorado 80045, USA
Barton BMC Medicine 2012, 10:46
http://www.biomedcentral.com/1741-7015/10/46
© 2012 Barton; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.patient-centered, timely, efficient, effective, and equitable
care [5]. As the United States has moved toward the devel-
opment of a national Health IT infrastructure, over 1,500
mobile medical applications have been developed to assist
both patients and their clinicians in managing care [6].
The growing use of these applications, as well as the
potential risks that those functioning as medical devices
may pose to public health, prompted the United States
Food and Drug Administration (FDA) to issue draft gui-
dance concerning the regulation of mobile medical appli-
cations in July 2011 [7]. The role of the FDA is to protect
consumers and enhance public health through maximizing
compliance with regulated products and minimizing risk.
The FDA has regulated medical devices for decades and is
proposing to extend these regulations for mobile medical
applications that function as medical devices.
Discussion
Several types of mobile medical applications are proposed
to be included in regulations (Table 1). One such exam-
ple is an application used as an extension of a device
such as a remote display of data from a bedside monitor.
It would be important to ensure that the displays are
consistent in the information provided to the clinician. A
second group of mobile medical applications that would
fall under regulations are those that use attachments, dis-
play screens, or sensors similar to an existing medical
device. Included in this category are applications which
attach a mobile device to a glucose strip reader. Once
again, accuracy is necessary for appropriate diagnosis and
intervention. Finally, mobile applications that are
designed to assist diagnosis or treatment using specific
patient data, such as calculation of medication dosage,
will require regulation. Over- or under-dosing may result
in serious patient harm. Thus, those applications that are
targeted for regulation perform the same function as a
currently regulated device, and could cause harm if they
fail to function as intended.
Obviously, those medical applications that are intended
to be used as devices are a relatively small proportion of
those available for use. There are several types of applica-
tions that are not being considered for regulation. First
and foremost, those applications that are used as refer-
ence guides (such as an electronic text book) for clini-
cians [8-10] or health and wellness records (for example,
diet and weight logs) for consumers [11-13] are not being
considered for regulation. However, applications that
might be used for dosage calculation [14,15] or digital
imaging [16,17], do fall under the new regulation gui-
dance. Applications that support office operations, or
those that are generic aids like a magnifying glass that
assist users but are not marketed for medical purposes
are also not included under the regulation guidance.
The American Medical Informatics Association sub-
mitted feedback concerning regulation of mobile medical
applications in a letter dated October 19, 2011. The
themes of that response included clarification of defini-
tions and use of terminology about medical mobile appli-
cations, the convergence of mobile and non-mobile
technologies, the functionality of applications, and the
Table 1 Mobile Medical Applications for which FDA will apply regulatory oversight
Description Examples
Mobile applications that are an extension of one or more medical device
(s) or displaying, storing, analyzing, or transmitting patient-specific
medical device data
Remote display of data from bedside monitors
Display of previously stored EEG waveforms
Display of medical images directly from a Picture Archiving and
Communication System (PACS) server
Control of inflation/deflation of a blood pressure cuff
Control of the delivery of insulin by an insulin pump
Mobile applications that transform the mobile platform into a medical
device by using attachments, display screens, or sensors or by including
functionalities similar to those of currently regulated medical devices
Attachment of a transducer to a mobile platform to function as a
stethoscope
Attachment of a blood glucose strip reader to a mobile platform to
function as a glucose meter
Attachment of electrocardiograph (ECG) electrodes to a mobile platform
to measure, store, and display ECG signals
Mobile applications that allow the user to input patient-specific
information and through the use of formulae or processing algorithms,
output a patient-specific result, diagnosis, or treatment recommendation
to be used in clinical practice or to assist in making clinical decisions
Mobile applications that provide a questionnaire for collecting patient-
specific lab results and either: (1) compute the prognosis of a particular
condition or disease; (2) perform calculations that result in an index or
score; (3) calculate dosage for a specific medication or radiation
treatment; or (4) provide recommendations that aid a clinician in making
a diagnosis or selecting a specific treatment for a patient
Adapted from: Draft Guidance for Industry and Food and Drug Administration Staff - Mobile Medical Applications http://www.fda.gov/medicaldevices/
deviceregulationandguidance/guidancedocuments/ucm263280.htm
The FDA defines a mobile medical application as one that meets the definition of a device (’... an instrument, apparatus, implement, machine, contrivance,
implant, in vitro reagent’ that is ‘intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease,
in man...’ or ‘... intended to affect the structure or any function of the body of a man or other animals...’) and is either ‘used as an accessory to a regulated
medical device or transforms a mobile platform into a regulated medical device’. This table summarizes information about the mobile medical applications that
will be subjected to regulation by the FDA. The table describes the mobile applications of interest and then provides specific examples of devices that would fall
under the regulation.
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methods [18].
Another concern related to the potential of mobile
health application regulations pertains to limiting inno-
vation and discovery. Several implications of regulation
from the perspective of a developer include additional
cost, lead time for production, complexity, and paper-
work [19]. For researchers, exemptions are possible, but
the fear is that innovation would be curtailed due to the
expanded length of time required to take a product to
market.
Recently, safety issues concerning the use of Health IT
have begun to surface, prompting the Office of the
National Coordinator to commission an analysis by the
Institute of Medicine (IOM) [20]. While no safety issues
with regard to medical mobile applications emerged in
their review, they cautioned that over-reliance on these
applications may create barriers for consumers who
have limited Internet connectivity and/or health literacy
resulting in an unintended exacerbation of health access
and disparity issues. Further, there are additional con-
cerns about maintaining health data in a confidential
manner across mobile computing platforms. In order to
track safety concerns, the IOM report contains a recom-
mendation for the Department of Health and Human
Services to ‘establish a mechanism for both vendors and
users to report health IT-related deaths, serious injuries,
or unsafe conditions’ [20].
Similar issues are noted in developing nations. While
penetration of mobile phone services is increasing, sev-
eral issues of web-enabled applications such as cost,
connectivity, coverage, low literacy, and high diversity of
users emerge. Even though opportunities for mobile
medical applications in developing countries seem pro-
found, there is lack of evidence to support widespread
use without careful testing and evaluation [21]. In fact, a
recent report recommends creation of a global infra-
structure for mobile medical applications to provide
‘common standards and guidelines, and serves as a repo-
sitory for shared resources and best practices’ [22]. Spe-
cifically, evaluation of mobile medical applications
should be strengthened to use methods such as compar-
ison studies and cost-benefit studies in which standar-
dized indicators, replicable study design, and adequate
sample sizes are employed to assess not only the tech-
nology, but the impact of the technology on health [23].
The International Organization for Standardization
recently released a new standard for medical devices
which incorporates a risk assessment framework to
establish technical or process standards [24]. Mobile
medical applications which function as medical devices
should be subject to the same standards in development,
manufacturing, and use.
Conclusions
Deliberations about the appropriateness of regulation of
mobile medical applications must take a patient-centered
approach. The FDA has provided initial guidance on their
perspective. With the broader contributions of members
of the healthcare and informatics communities, from both
private and public sectors, regulations will likely be appro-
priate and reasonable, provided those regulations are
applied to mobile medical applications that present poten-
tial risk for public health. The Hippocratic notion of ‘do
no harm’ should be of primary consideration. Moving for-
ward, it will be necessary to achieve a balance for ensuring
patient safety while supporting innovation in the develop-
ment and use of mobile medical applications.
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